Wanling Lin

机构：Peking University, Peking University People's Hospital

发表论文 18 篇 · 总被引 1205 次 · h-index 6

代表论文

• Notch signaling pathway: architecture, disease, and therapeutics (2022 · Signal Transduction and Targeted Therapy · 被引 1091)
• SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway (2022 · Journal of Cancer · 被引 42)
• Sitagliptin Alleviates Radiation‐Induced Intestinal Injury by Activating NRF2‐Antioxidant Axis, Mitigating NLRP3 Inf‐‐lammasome Activation, and Reversing Gut Microbiota Disorder (2022 · Oxidative Medicine and Cellular Longevity · 被引 30)
• Combined inhibition of MET and VEGF enhances therapeutic efficacy of EGFR TKIs in EGFR-mutant non-small cell lung cancer with concomitant aberrant MET activation (2024 · Experimental Hematology and Oncology · 被引 18)
• Nodular fasciitis of the breast: the report of three cases (2022 · BMC Women s Health · 被引 9)
• Investigating early progression of Hodgkin lymphoma in a two-center analysis (2022 · Journal of the Formosan Medical Association · 被引 6)